LivaNova Plc (LIVN)
74.98
-1.45
(-1.90%)
USD |
NASDAQ |
Oct 06, 16:00
74.98
0.00 (0.00%)
After-Hours: 20:00
LivaNova EPS Diluted (Quarterly) : 1.929 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.929 |
| March 31, 2026 | 0.3985 |
| December 31, 2025 | 0.5566 |
| September 30, 2025 | 0.4856 |
| June 30, 2025 | 0.4965 |
| March 31, 2025 | -6.015 |
| December 31, 2024 | 1.022 |
| September 30, 2024 | 0.6037 |
| June 30, 2024 | 0.2992 |
| March 31, 2024 | -0.7766 |
| December 31, 2023 | 0.2999 |
| September 30, 2023 | -0.1356 |
| June 30, 2023 | 0.0214 |
| March 31, 2023 | 0.1367 |
| December 31, 2022 | 0.0311 |
| September 30, 2022 | -2.005 |
| June 30, 2022 | 0.3041 |
| March 31, 2022 | 0.0552 |
| December 31, 2021 | -0.0964 |
| September 30, 2021 | -0.8422 |
| June 30, 2021 | -1.154 |
| March 31, 2021 | -0.6312 |
| December 31, 2020 | -5.774 |
| September 30, 2020 | -0.3036 |
| June 30, 2020 | -1.810 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.791 |
| December 31, 2019 | -2.959 |
| September 30, 2019 | 0.6579 |
| June 30, 2019 | -0.6043 |
| March 31, 2019 | -0.3078 |
| December 31, 2018 | -4.342 |
| September 30, 2018 | -0.1476 |
| June 30, 2018 | 0.3097 |
| March 31, 2018 | 0.2698 |
| December 31, 2017 | -2.317 |
| September 30, 2017 | 0.5734 |
| June 30, 2017 | 0.9833 |
| March 31, 2017 | 0.2339 |
| December 31, 2016 | -0.61 |
| September 30, 2016 | -0.03 |
| June 30, 2016 | 0.18 |
| March 31, 2016 | -0.83 |
| January 31, 2015 | 0.62 |
| October 31, 2014 | 0.64 |
| July 31, 2014 | 0.50 |
| April 30, 2014 | 0.68 |
| January 31, 2014 | 0.51 |
| October 31, 2013 | 0.50 |
| July 31, 2013 | 0.31 |
| April 30, 2013 | 0.41 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Smith & Nephew plc | -- |
| NovoCure Ltd. | -0.135 |
| Tristel Plc | -- |
| EKF Diagnostics Holdings Plc | -- |
| Niox Group Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 108.57M |
| Revenue (Quarterly) | 390.59M |
| Total Expenses (Quarterly) | 282.02M |
| Enterprise Value | 4.043B |
| Gross Profit Margin (Quarterly) | 70.32% |
| Profit Margin (Quarterly) | 27.80% |
| Earnings Yield | 4.49% |
| Operating Earnings Yield | 5.29% |
| Normalized Earnings Yield | 6.734 |